https://necrosulfonamideinhibi....tor.com/atorvastatin
The current study's findings highlight two distinct TME classifications in NPC patients. A higher level of immune cells and immune checkpoint genes are observed in patients with the S1 subtype, signifying a more positive prognosis. We built machine learning models, using expression data profiles from NPC patients, to predict the TME subtypes within the patient population. This model's genetic composition includes eight genes, nam
Like
Comment
Share
